Cashu | News | NERV

HomeWatchlistNewsSignalsPicks

DJI

+0.16%

SPX

+0.43%

IXIC

+0.51%

FTSE

-0.22%

N225

-0.13%

AXJO

-0.36%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Minerva Neurosciences News

Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors

Klotho Neurosciences (KLTO) Stock Surges Over 680%: What's Going On?

Feature Image for interests on Consumer Cyclical, CryptoCurrency, Healthcare, News from benzinga.com

Amygdala Neurosciences Selects ANS-858 for Clinical Development as a Novel ALDH2 Inhibitor for Substance Use Disorder

Feature Image for interests on Clinical Trials & Medical Discoveries, Consumer Cyclical, Health Care & Hospitals, Healthcare from prnewswire.com

finance.yahoo.com

ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now

Feature Image for interests on Bank Of Canada, Canadian Stocks, ETF, Earnings Reports from finance.yahoo.com

finance.yahoo.com

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Feature Image for interests on Advisory Board, Biotechnology Company, Bob Langer, Dr from finance.yahoo.com

finance.yahoo.com

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Feature Image for interests on Advisory Board, Biotechnology Company, Bob Langer, Dr from finance.yahoo.com

finance.yahoo.com

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

Feature Image for interests on Company, Healthcare, Klotho Gene, Neurodegenerative Diseases from finance.yahoo.com

finance.yahoo.com

ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences

Feature Image for interests on Ad, Alzheimer’S Disease, Antibody Therapeutics, Healthcare from finance.yahoo.com

businesswire.com

Apple introduces groundbreaking health features to support conditions impacting billions of people

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

businesswire.com

Apple introduces groundbreaking health features to support conditions impacting billions of people

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

Stocks

Health Care

nerv

Minerva Neurosciences

NERV

-0.04 (-2.21%)

1.77

USD

At close at Jun 23, 14:39 UTC

Latest Cashu News

Minerva Neurosciences Appoints Dr. Gail M. Farfel to Strengthen Leadership for Phase 3 Trials

Minerva Neurosciences Appoints Dr. Gail M. Farfel to Strengthen Leadership Ahead of Phase 3 Trial

Minerva Neurosciences Strategizes in Response to Anti-Aging Sector Developments and Competitive Trends